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Abstract

Hypertension is associated with elevated rates of
collagen synthesis and deposition in the arterial wall.
Whether the increased synthesis and accumulation of vascular
collagen is a cause or an effect of the elevated blood
pressure in animal models of hypertension is still
unresolved. Previous studies in this laboratory have
indicated that chronic streptozotocin (STZ)-induced diabetes
(8 weeks) reduces systolic arterial pressure (SAP) and
vascular collagen synthesis in the spontaneously
hypertensive rat (SHR) without affecting either measurement
in the normotensive Wistar-Kyoto (WKY) strain. It was not
apparent from those studies whether the reductions in SAP
and vascular collagen synthesis in the diabetic SHR were
causally or coincidentally related. Others have shown that
diabetes does not affect SAP in the Goldblatt renovascular
hypertensive (RVH) rat. Its effects on vascular collagen
synthesis in the RVH model of hypertension has not been
investigated. Aortic collagen synthesis was measured in
diabetic and non-diabetic RVH and WKY rats in order to
determine whether diabetes affects vascular collagen
synthesis indirectly through changes in SAP, or whether
diabetes affects vascular smooth muscle (VSM) collagen
synthesis by a different mechanism. Vascular collagen
synthesis was quantified by measuring the incorporation of

[ 14 c]-proline into collagen-bound [ 14 c]-hydroxyproline in
ii

rat aortic minces in vitro. Aortic prolyl hydoxylase (PH; a
collagen biosynthetic enzyme) activity was also measured as
an index of collagen biosynthesis. Compared to
vehicle-injected controls, rats injected with STZ exhibited
the weight-loss, elevated serum glucose, and reduced serum
insulin and thyroid hormone levels characteristic of the
diabetic state. Renovascular hypertension caused an increase
in vascular PH activity and . collagen synthesis, presumably
through an increase in arterial wall tension. Diabetes
significantly reduced vascular collagen biosynthesis and PH
activity in the RVH and WKY rat without affecting SAP of
either group. Diabetes and hypertension had no significant
effects on aortic collagen concentration. These results
suggest that experimental diabetes inhibits vascular
collagen synthesis by a mechanism independent of a reduction
in arterial pressure. The mechanism by which diabetes
reduces VSM collagen synthesis in the rat is unknown, but
may involve hypoinsulinemia, hypothyroidism, or autonomic
neuropathy.
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Introduction

Experimental diabetes mellitus inhibits the synthesis
of collagen by vascular smooth muscle (VSM). Both
chemically-induced diabetes (streptozotocin; STZ) and
genetic diabetes are characterized by reduced rates of
aortic collagen synthesis in the rat (Schneir et al., 1979;
Bowersox and Sorgente, 1985). Administration of insulin in
vitro to vascular tissue obtained from diabetic animals

partially restores the depressed rates of collagen synthesis
toward normal (Mikkonen et al., 1966; Arnquist and Norrby,
1980). The evidence suggests that insulin regulates VSM
collagen synthesis, but leaves open the possibility that
other factors may be involved.

The rate of collagen synthesis by VSM is also
influenced by arterial pressure, and the resultant stress on
the arterial wall (Gilligan and Spector, 1984). Elevated
wall stress produced by hypertension is consistently
associated with increases in arterial VSM collagen synthesis
and collagen content (Wolinsky, 1970, 1971; Foidart et al.,
1978), regardless of the experimental model of hypertension.
Both prolyl hydroxylase (PH; a collagen biosynthetic enzyme)
activity and the incorporation of radiolabelled proline into
collagen (a more direct measure of collagen synthesis) are
elevated in the desoxycorticosterone acetate (DOCA)-salt and

2 .
spontaneously hypertensive rat (SHR) models of hypertension
(Iwatsuki et al., 1977a). Antihypertensive therapy usually
prevents or reverses the elevated rates of VSM collagen
synthesis (Ooshima et al., 1974), most likely by reducing
arterial pressure rather than by a direct action on the
vascular smooth muscle cell (Oshima et al., 1983).

Diabetes can affect arterial pressure, especially of
hypertensive animals. In the absence of hypertension,
diabetes produces small and variable changes in blood
pressure (Cavaliere et al., 1980; Pfaffman, 1980; Sasaki and
Bunag, 1982; Rodrigues and McNeill, 1986; Rodgers, 1986;
Ganguly et al., 1987). However, in the SHR, chronic diabetes
of several weeks duration consistently reduces systolic
arterial pressure (SAP), occasionally restoring SAP to the
levels of nonhypertensive controls (Somani et al., 1979;
Cavaliere et al., 1980; Rodrigues and McNeill, 1986;
Rodgers, 1986; Yamamoto and Nakai, 1988). This depressor
(pressure-lowering) effect of diabetes may be dependent on
the experiemntal model of hypertension. Diabetes does not
affect SAP in the DOCA-salt (Sasaki and Bunag, 1982) or the
renovascular hypertensive (RVH) rat (Factor et al., 1981;
Fein et al., 1984). The mechanism for the selective effect
of diabetes on SAP in the SHR strain remains to be
clarified.

3

Recent work in this laboratory indicates that diabetes
exerts a much more profound effect on VSM collagen synthesis
in the SHR than it does in the nonhypertensive WKY control
strain. STZ-induced diabetes reduced SAP in vivo, and caused
a depression in several indices of collagen synthesis by
aortic segments in vitro, in the SHR (Rodgers et al., 1985;
Sessa et al., manuscript in preparation). In contrast,
diabetes of equal severity and duration had no effect on SAP
or vascular collagen synthesis in the normotensive WKY
control. These observations led to two alternative
hypotheses. Diabetes may have reduced VSM collagen synthesis
in the SHR indirectly through its influence on SAP.
Alternatively, the reductions in VSM collagen synthesis and
SAP in diabetes may have been coincidental and unique to the
SHR strain.

The purpose of the present study was to provide
additional evidence to distinguish between these
possibilities. Arterial pressure and aortic PH activity and
collagen synthesis were measured in diabetic and
non-diabetic RVH and WKY rats. The lack of a depressor
effect of diabetes in the Goldblatt RVH rat, in contrast to
its depressor effect in SHR, provides a model system to
determine whether diabetes reduces vascular collagen
synthesis indirectly through a reduction in SAP, or whether
diabetes reduces vascular collagen synthesis by a mechanism
independent of this phenomenon. This study also enabled us

4

to determine whether the depressor effect of diabetes in the
SHR was unique to that strain.

5
Experiemntal

Animal preparation

Male Wistar-Kyoto (WKY) rats were purchased from
Charles River Breeding Labs (Wilmington, MA), housed five
per cage, and maintained on standard rat chow (Agway Inc.,
Syracuse, NY) and tap water ad libitum. At 12 weeks of age,
"two-kidney, one-clip" Goldbaltt renovascular hypertension
was induced by placing a silver clip (internal diameter 0.20
mm) on the left renal artery and leaving the contralateral
kidney intact (Goldblatt et al., 1934). Sham-operated WKY
animals served as ?Ormotensive controls. The clip size was
chosen so as to yield maximal sustained hypertension (Murphy
et al., 1984). Systolic arterial pressure (SAP) was

determined weekly by the standard tail cuff method after
warming the animals in a thermoregulated chamber (32°c x 20
min.). All SAP values are means of four to six measurements
recorded after the blood pressure had stabilized. Three to
four weeks after surgery (15-16 weeks of age), the clipped
animals with an SAP of 160 mmHg or greater were included in
the hypertensive group, while the remaining normotensive
animals were excluded from the study. Hypertension was
produced in approximately 65-70% of the clipped animals. A
randomly selected subgroup of each of the hypertensive and
sham-operated normotensive animals was made diabetic with a

6
single tail vein injection of streptozotocin (STZ; 50 mg/Kg
in 0.10 M citrate buffer, pH 4.5) under light ether
anesthesia. Prior to STZ injection, the mean SAP values of
the two treatment subgroups within each group were not
significantly different from each other. The respective
controls received an equal volume of the citrate buffer
alone. Thus, four experimental groups comprised the study:
1) renovascular hypertensive nondiabetic control, 2)
renovascular hypertensive-diabetic, 3) sham-operated WKY
normotensive nondiabetic control, and 4) sham-operated

WKY

normotensive diabetic. Diabetes was monitored weekly by
urinary glucose measurement (DiastixR). In addition, heart
rate and body weight were also monitored weekly throughout
the study. Groups 1-4 were sacrificed at 24 weeks of age
following 8 weeks of diabetes. In a separate study, groups
1-3 were sacrificed at 18 weeks of age, 3 weeks after STZ
injection. All animals were killed by rapid decapitation and
blood was collected for the assay of serum glucose, T , T ,
3
4
and insulin levels.

Serum glucose, insulin, T , and T determinations
3
4

Serum glucose was measured colorimetrically by the
glucose oxidase method using a kit purchased from the Sigma
Chemical Company (St. Louis, MO). Serum T , T , and insulin
3
4
were measured by radioimmunoassay with kits purchased from

7

Cambridge Diagnostics (Cambridge, MA). All serum
determinations were kindly performed by F. Pinnault in our
laboratory.

Determination of collagen synthesis

Aortic collagen biosynthesis was characterized by
.
.
.
measuring
t h e extent o f 1ncorporat1on
·o f

u- 14 C-L-pro l'ine

into [ 14 c]-hydroxy-L-proline at a single time point in
vitro. The activity of prolyl hydroxylase (PH) was measured
in cell-free aortic homogenates. At sacrifice the thoracic
aorta extending from the arch to the diaphragm was excised
and cleaned of perivascular tissue. When prolyl hydroxylase
activity was to be measured, the aorta was cut in half
longitudinally and one half was immediately frozen for
prolyl hydroxlase determination at a later time. The aorta
was minced and incubated in 2mL of gassed (95% o , 5% co )
2
2
Krebs-Henseleit (K-H; Rodgers et al., 1985) buffer solution
(pH 7.4) supplemented with U-[

14

c]-L-proline (lOuCi/mL;

specific activity 268.1 uCi/umole) and ascorbate (0.50 mM)
at 37°c for 6 hours. It has been previously shown in this
laboratory that aortic collagen rates are linear for up to
10 hours under these conditions (Sessa et al., 1986). After
incubation, protein synthesis was halted by replacing the
K-H buffer with 2 mL ice-cold saline containing
cycloheximide (O.lOmg/mL) and incubating on ice for 20
minutes.

8

An experiment was done to test the effect of carrier
L-proline on the rate of aortic collagen synthesis in vitro,
as Peterkofsky et al. (1982) have found that this treatment
enhances the uptake of proline into the cell. This may in
turn affect the rate of collagen synthesis by expansion of
the intracellular proline pool. It was found, however, that
carrier proline did not enhance collagen synthesis in the
rat aorta. The results are presented and discussed in
Appendix 1.

An aliquot of the whole homogenate was taken for the
assay of NaOH-soluble protein by the method of Lowry et al.
(1951) as follows. Fifty uL of the homogenate was added to
450 uL of lN NaOH, allowed to stand 1 hour at room
temperature, and then centrifuged for 15 minutes in a
Beckman tabletop refrigerated centrifuge. Two 200 uL
aliquots were removed from each sample and immediately
frozen for future protein determination.

Proteins were precipitated by the addition of 50%
ice-cold trichloroacetic acid (TCA) to yield a final
concentration of - 5%, and washed 6 times with ice-cold 5% TCA
14
to remove unincorporated c c]-proline. Residual TCA was
removed with 3 ethanol-ether washings (3:1, v/v) followed by
3 washings with anhydrous ether. The protein pellet was
hydrolyzed in 6N HCl for 20 hours at 110°

c.

The

hydrolysates were filtered, and the filtrate was evaporated

9

to dryness, resuspended in distilled water and evaporated to
dryness again to remove residual HCl. The dried residue was
was stored at -10°c until the time of analysis by high
performance liquid chromatography (HPLC).

HPLC sample preparation

The sample residue was resuspended in 0.40 mL of 0.10 M
potassium tetraborate (pH 9.5) at which time a thick whitish
precipitate would form. A 100 uL aliquot of the suspension
was placed in a microcentrifuge tube and centrifuged at 6000
x g for 5 minutes. The supernatant fluid was removed and
saved, the pellet was washed twice with 150 uL of the
tetraborate buffer, and all the washings were added to the
supernatant fluid. The volume of the combined supernatant
fluid and washings was adjusted to 480 uL with 0.10 M
tetraborate, and 20 uL of 5 mM cis-4-hydroxy-L-proline was
added as an internal standard. Cis-4-hydroxy-L-proline
(cis-hypro) was chosen as the internal standard because of
its absence from naturally occuring proteins and its
convenient elution pattern between trans-4-hydroxy-L-proline
(trans-hypro) and L-proline during separation by HPLC. An
epimerization reaction does occur during hydrolysis in which
approximately 10% of the trans-hypro is converted to the cis
form of the molecule (Berg, 1982), but this was taken into
account in the calculation of collagen synthetic rates (see

10
Data Analysis). The identity of the precipitate remains
unknown; however it was determined that neither proline nor
hydroxyproline were components of the precipitate itself
but, rather, were trapped within the matrix of the pellet.
Greater than 99% of the radioactivity could be removed from
the pellet by 4-5 washings, and in the present experiments
approximately 3-5% of the total radioactivity remained in
the pellet after the two tetraborate washes. Values for
incorporation of proline into collagen were not corrected
for the 3-5% of radioactivity remaining in the washed
pellet.

Imino acid derivatization and HPLC analysis

4-chloro-7-nitrobenzofurazan (NBD-Cl) is a derivatizing
agent used to label secondary

amine~.

The reaction of NBD-Cl

with secondary amino acids such as hydroxyproline and
proline occurs at a rate 10 times faster than that for
primary amino acids (Ahnoff et al., 1981). The resulting
fluorescent derivatives can be seperated by reversed-phase
HPLC and quantified by fluorescence spectroscopy with a high
degree of sensitivity. The derivatization and
chromatographic conditions were those of Ahnoff et al.
(1981) and Lindblad and Dieglman (1984) as modified by Sessa
et al. (1986) for

the quantification of collagen

biosynthetic rates in vascular tissue.

An equal volume of

11
NBD-Cl (20 mM) was added to 500 uL of the resuspended,
washed hydrolysate and incubated in the dark at 60°c for 3
minutes. The reaction was stopped by immersion in an
ice-bath and the addition of 0.10 mL 6N HCl. A 100 uL aliqot
was taken for separation and analysis by reversed-phase
HPLC.

The HPLC system consisted of a Waters M-45 constant
flow pump, an ISCO Isis autosampler, and a Gilson
Spectraglow flourimeter connected to a Shimadzu CR-3A
chromatopac integrator. Separation was performed on a 30 cm
x 3.9 mm i.d. 10 micron silica uBondpak c
by a guard column with c

18

18

column preceded

pellicular packing. The mobile

phase consisted of 24.5% acetonitrile and 0.08% phosphate
(pH 2.30) and was degassed by vacuum suction for 30 minutes.
Separation was performed isocratically with a flow rate of
1.6 mL/min. at room temperature. Fractions (0.80 mL) were
collected and radioactivity was measured by liquid
scintillation spectroscopy in a Packard Tri-CarbR 4000
Series liquid scintillation counter. Quenching caused by the
yellow fluorescent color was corrected for by using the
quenching index parameter function of the Packard counter,
but in most cases the amount of quenching was minimal. The
counting efficiency averaged 88-90%.

12
Data Analysis

Collagen synthesis was determined by the amount of
radioactivity collected under the trans- and cis-hypro peaks
(any radioactive cis-hypro arises from trans-hypro due to
epimerization during hydrolysis), and expressed as
disintegrations per minute (dpm) hypro formed per umole
hypro (specific activity) per 6 hour incubation. Collagen
concentration was expressed as nmole hypro per mg. protein.
Total umoles of hydroxyproline were quantified by comparing
the ratio of of trans- and cis-hydroxyproline peak heights
of each sample to those generated from standards. A separate
standard curve was generated for each set of samples
analyzed by HPLC on any given day. The underivatized praline
and hydroxyproline eluted in the first few fractions of each
sample, and the percent derivitization was calculated by
dividing the underivatized radioactivity by the total
radioactivity recovered from each sample. All samples were
corrected for percent derivatization (mean 90 + 5%) in the
calculation of collagen synthetic rates.

Prolyl hydroxylase assay

The assay of aortic praline hydroxylase (praline,
2-oxo-glutarate dioxygenase) was a modification of the
method of Hutton et al. (1966) employing a 3,4- 3 H-proline

13
labelled substrate prepared from 8 day-old chick calvaria
bones. Aortic tissue was thawed after approximately one week
at -10°c and homogenized in 0.50 mL of a buffer containing

0.25M sucrose, 50mM tris-HCl, lOmM EDTA, lOmM
dithiothreitol, and 0.01% Triton X-100, pH 7.4. The
homogenate was centrifuged at 15000 x g. for 20 minutes. A

0.20 mL aliquot of the supernatant fluid was incubated with
substrate (denatured at 45°c for 30 minutes; approximately

400,000 cpm per tube) and cofactors necessary for proline
hydroxylation for 30 minutes at 30°c. The cofactors and
their final concentrations are as follows:
Fe(NH ) (so )"6H o (O.lmM), sodium ascorbate (O.lmM), alpha
4 2
4
2
ketoglutarate (O.lmM), and bovine serum albumin (0.2%). The
reaction was buffered at pH 7.4 with Tris-HCl (0.05M).

The activity of prolyl hydroxylase was quantified by
determining the amount of tritium released during incubation
and collected as tritiated H o by vacuum distillation. The
2
amount of protein in the 15,000 x g. supernatant fluid was
determined by the Lowry method, and prolyl hydroxylase
activity was expressed as cpm per mg. protein.

14
Statistical anylysis

Multiple comparisons between groups and treatments were
made using analysis of variance (ANOVA) followed by Student
Neuman-Keuls (Statistical Analysis Systems, Cary, NC).
Single comparisons were made using the unpaired Student's t
test. Significance was restricted to p < 0.05.

15

Results

The effects of streptozotocin (STZ)-induced diabetes of
8 weeks duration on serum measurements and body weight of
renovascular hypertensive and normotensive rats are
summarized in Table 1. Injection of STZ increased the serum
glucose levels of both the hypertensive and normotensive
groups to approximately the same extent. The serum insulin
levels were similar in both of the nondiabetic control
groups, and these levels were reduced to a similar degree by
diabetes in both the hypertensive and normotensive diabetic
animals. By these criteria, then, the degree of diabetes
induced by STZ in the hypertensive group was similar to that
of the normotensive animals. Serum thyroxine and
triiodothyronine were also measured and found to be
significantly reduced in the diabetic animals, indicating
that STZ-induced diabetes is accompanied by hypothyroidism.
Interestingly, serum T

3

in the renovascular hypertensive

nondiabetic control was slightly but significantly lower
than the corresponding WKY control group, while serum T

4

levels in these control groups were not significantly
different from each other. The body weights of the
hypertensive and normotensive controls were not
significantly different from each other 12 weeks after
surgery. Eight weeks of diabetes significantly reduced body
weight in the RVH and WKY groups by 20% and 16%

16

Table 1. Serum glucose, insulin, T 3 , and T 4 , and body weight
of renovascular hypertensive (RVH) and normotensive
Wistar-Kyoto (WKY) rats following 8 weeks of experimental
diabetes. Values are means + S.D. Diabetes was induced 3-4
weeks after surgery (15-16 weeks of age) with a single tail
vein injection of streptozotocin (STZ; 50 mg/Kg) and the
animals were sacrificed 8 weeks thereafter.

Table 1

Glucose

Insulin
(uU/mL)

Group

Treatment

!!.

(mg/dL)

RVH

control

7

127 + 11

diabetic

7

426 + 55

control

5

116

diabetic

7

395 + 62

WKY

2

+ 34

T3

(ug/mL)

Body weight

(ug/mL)

(grams)

53.0 + 22.6

70.2 + 15.0

1

5.22 + 1.62

+ 2.8 2

41.9 + 10.3

2

2.59 + 0.60

1.8

49.0 + 9.5
2

T
4

1.9 + 3.0

2

86.0 + 15.5

4.9 + 0.13

2

2.72 + 0.36

41.3 + 6.5

344 + 47
2

274

+ 33 2

378 + 32
2

319 + 26

2

1

Significantly different from the WKY control (p < 0.05).

2Significantly different from the control of the same group (p < 0.05).

I-'
-...J
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respectively. The mean body weights of the four groups
studied were not significantly differerent from each other
at the time of STZ or citrate buffer injection.

Figure 1 depicts the effects of diabetes on systolic
arterial pressure (SAP) and heart rate (HR) in RVH and WKY
rats. The SAP rose rapidly following surgery in the clipped
animals and remained significantly elevated over the
sham-operated controls for the duration of the study.
Diabetes had no effect on SAP at any time point in either
the hypertensive or normotensive groups.

The SAP in the

nondiabetic and diabetic RVH animals following 8 weeks of
diabetes (12 weeks post-surgery) was 221 + 29 and 200 + 30
mmHg, respectively. Following 8 weeks of diabetes the SAP in
the nondiabetic and diabetic WKY groups were 137 + 4 and 126

+ 7 mmHg, respectively. The changes in heart rate observed
in the hypertensive and diabetic state were more varied than
the changes seen in systolic arterial pressure. The heart
rate rose in parallel with SAP following surgery in the RVH
animals and was significantly elevated over the normotensive
WKY 2 and 3 weeks after renal artery clipping. However, the
HR in the RVH control and diabetic groups was not
significantly different from the normotensive control during
the following 5 weeks, due in part to a transient elevation
in the HR of the WKY nondiabetic control group. Heart rate
in the RVH control group was significantly greater than the
WKY control during the last four weeks of the study (9-12

19

Figure 1. The effect of streptozotocin (STZ)-induced
diabetes on systolic arterial pressure (SAP; A) and heart
rate (HR; B) of renovascular hypertensive (RVH) and
Wistar-Kyoto (WKY) rats. Animals were injected with STZ

3-4

weeks after · surgery (15-16 weeks of age) and sacrificed
following 8 weeks of diabetes (b). In addition, a group of
RVH and WKY nondiabetic control animals was sacrificed 6
weeks following surgery (18 weeks of age; a). Vertical
brackets indicate 1 S.D. The groups and their symbols are as
follows: RVH nondiabetic, open triangles; RVH diabetic,
closed triangles; WKY nondiabetic, open circles; WKY
diabetic, closed circles.

* Significantly

different from the WKY nondiabetic control.

tSignificantly different from the control of the same group.
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weeks after surgery). Heart rate was significantly reduced
in the RVH diabetic versus nondiabetic 6 and 8 weeks
following STZ injection, while diabetes reduced HR in the
WKY animals only at week 3 following injection. In general,
8 weeks of diabetes reduced HR in the RVH animals, while it
had no effect on SAP at any point during the study. In the
WKY animals, diabetes affected heart rate at only a single
early time point, while, similar to the RVH animals,
diabetes had no effect on SAP throughout the eight week
period.

Aortic collagen synthesis after 8 weeks of
streptozotocin-induced diabetes is presented in Table 2.
Collagen synthesis was also measured in hypertensive
diabetic and nondiabetic animals 3 weeks after STZ or
vehicle injection (6 weeks after surgery), but the data was
not included in Table 2 because the severity of diabetes was
in question (see Appendix 3). Aortic collagen synthesis is
expressed as dpm hydroxyproline incorporated into collagen
per urnole total hydroxyproline (specific activity) during
the 6 hour incubation period. Aortic collagen synthesis was
significantly elevated in the RVH control 12 weeks after
renal artery clipping. Eight weeks of diabetes significantly
reduced collagen synthesis in the RVH and WKY groups by 55%
and 72%, respectively.
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Table 2. Aortic collagen synthesis in renovascular
0..

r-

hypertensi ve (RVH) and Wistar-Kyoto (WKY) rats t6 and 12

week~ following surgery. Values are means + S.D.
Collagen Synthesis

(dpm hypro/ umole hypro x 10- 3 )

Group a

Treatment

n

RVH

control

10

WKY

72.5 -+ 28.5 1
32.7 -+ 11.6 2

diabetic

9

control

8

58.3 + 27.9

diabetic

7

16.2 + 3.9 2

aThe RVH and WKY animals were sacrificed 12 weeks following
surgery and 8 weeks following STZ injection
1 significantly different from WKY control.
2signif icantly different from control of the same group.
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Collagen synthesis has also been expressed as dpm
hydroxyproline per mg. protein (Ooshima et al., 1977;
Iwatsuki et al., 1977a); however, this expression of the
data was not included in Table 2 because diabetes also
affects total protein content of various tissues (see
Appendix 2).
The conaentration of collagen in the aortas of 8 week
diabetic RVH and WKY rats are shown in Table 3. Collagen
concentration is expressed as nanomoles hydroxyproline per
mg. total protein. Although there were no statistically
significant differences between any of the groups, certain
trends are suggested. The aortic collagen concentration of
the 3 week diabetic group is presented and discussed in
Appendix 3.

Table 4 shows the effects of diabetes of 8 weeks
duration on aortic prolyl hydroxylase (PH) activity in the
hypertensive (RVH) and normotensive (WKY) rat. The activity
of this collagen biosynthetic enzyme paralleled the overall
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Table 3. Collagen concentration in aortas of renovascular
hypertensive (RVH) and Wistar-Kyoto (WKY) rats 6 and 12
weeks following surgery. Values are means + S.D.

Collagen concentration
(nMole hypro/mg. protein)
Group

Treatment

n

6 weeks

n

12 weeksa

RVH

control

8

385 + 68

7

430 + 91

7

601 + 220

5

588 + 108

7

591 + 171

diabetic

WKY

control
diabetic

7

444 + 80

aThe 12 week RVH and WKY rats were diabetic for 8 weeks.
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Table 4. Aortic prolyl hydroxylase (PH) activity in
renovascular hypertensive (RVH) and Wistar-Kyoto (WKY) rats
after 8 weeks of diabetes. Values are means + S.D. and
expressed as cpm per mg. protein.

Group

Treatment

n

PH Activity

RVH

control

14

5213 -+ 2592

diabetic

12

2355 -+ 1449 2

control

14

3306 -+ 1671

WKY

1

All animals were sacrificed 12 weeks after renal artery
clipping (RVH) or sham operation (WKY).

1
2

signif icantly different from the nondiabetic WKY control
signif icantly different from the nondiabetic control of the
same group.
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rate of collagen synthesis measured by the incorporation of
14 c-proline into 14 c-hydroxyproline (Table 3). Twelve weeks
after renal artery clipping, aortic PH activity in the RVH
control was significantly greater than that in the WKY
control. Eight weeks of diabetes reduced PH activity in the
aortas of RVH rats to, and even below, normotensive values.
Aortic PH activity was not determined in the WKY diabetic
rat.
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Discussion

One prominent finding in this study is that the rate of
aortic collagen biosynthesis in the renovascular
hypertensive (RVH) rat is significantly elevated over that
in the normotensive WKY control, 12 weeks after renal artery
clipping (Table 2). Collagen synthesis was not significantly
elevated in the RVH rats 6 weeks after the induction of
hypertension (p

= 0.07).

This may have been due to the high

variability in the synthetic rates in both the RVH and WKY
groups. The aortic prolyl hydroxylase (PH) activity
paralleled the rate of aortic collagen biosynthesis in the
hypertensive and normotensive rats 12 weeks following
surgery (Table 3). These findings are in line with the large
body of evidence indicating that elevated arterial pressure
is associated with an increase in PH activity and collagen
biosynthesis in the blood vessel wall (Gilligan and Spector,
1984). It is still unclear, however, whether the elevated
arterial pressure is a cause or an effect of the elevated
synthesis and accumulation of vascular collagen. There is
evidence in the literature supporting both of these
possibilities. Both vascular collagen and noncollagen
protein synthesis are increased in SHR before blood pressure
is significantly elevated (4-5 weeks of age; Yamabe and
Lovenberg, 1974; Deyl et al., 1987). Iwatsuki et al. (1977b)
examined the role of vascular collagen in the development
and maintenance of elevated arterial pressure in the
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DOCA-salt hypertensive rat using the lysyl oxidase inhibitor
beta-aminoproprionitrile (BAPN). Lysyl oxidase (LO) is
involved in the crosslinking of newly synthesized collagen
fibrils. Inhibition of this enzyme reduces the number of
lysine-derived crosslinks, which increases the solubility of
collagen and renders it more susceptible to proteolytic
degradation (Vater et al., 1979). Iwatsuki et al. reported
that BAPN delayed the onset and partially reversed the
elevated arterial pressure in DOCA-salt hypertensive rats.
This was accompanied by a reduction in vascular collagen
content in these animals. This study suggests that vascular
collagen accumulation may be responsible in part for the
development and maintenance of elevated blood pressure in
the DOCA-salt model of hypertension. The findings of
Gilligan et al. (1982) partially support this hypothesis.
They showed that 8 weeks of clonidine (a sympatholytic
antihypertensive agent) treatment reduced arterial pressure
and vascular collagen synthesis and content in the DOCA-salt
hypertensive rat to normotensive levels. Arterial pressure
and collagen synthesis remained normal after discontinuation
of clonidine treatment, suggesting that the restructuring of
the arterial wall in itself may be sufficient to halt the
progression of hypertension in the DOCA-salt model. There
are studies, however, which report a dissociation between
arterial pressure and vascular collagen synthesis or content
in several models of hypertension. Both reserpine and
captopril prevent the increase in blood pressure in the
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Goldblatt one-kidney, one-clip (lK-lC) RVH rat, but only
reserpine prevented the increase in aortic collagen
deposition in this model (Rorive et al., 1980). Treatment of
DOCA-salt hypertensive rats with the prolyl hydroxylase
inhibitor P-1894B for 6 weeks prevented the rise in PH
activity and collagen synthesis in the thoracic aorta and
mesenteric artery without affecting the development of
elevated arterial pressure (Fukumoto et al., 1984). Franklin
et al. (1982) examined the effect of BAPN and 3,4
dehydroproline (DHP; substitutes for praline and results in
the synthesis of defective collagen) on arterial pressure
and aortic collagen content in the spontaneously and
DOCA-salt hypertensive · rat. In the SHR, BAPN reduced
arterial pressure without reducing aortic collagen content.
Both BAPN and DHP prevented the increase in aortic collagen
content in the DOCA-salt rats, but only BAPN prevented the
rise in blood pressure. These results suggest that BAPN may
have a depressor effect in hypertensive animals independent
of its effect on vascular collagen accumulation, and
therefore the reductions in arterial pressure and vascular
collagen content in BAPN treated hypertensive animals may be
coincidental. BAPN also reduGes vascular collagen content in
normotensive rats without affecting arterial pressure
(Iwatsuki et al., 1977b). Gilligan et al. (1982) showed that
clonidine treatment also reduced arterial pressure and
vascular collagen synthesis and content in the SHR. However,
discontinuation of clonidine treatment resulted in an
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increase in both blood pressure and vascular collagen
synthesis, suggesting that arterial pressure is a regulator
of vascular collagen biosynthesis in this model. To directly
examine the role of arterial pressure in regulating vascular
collagen biosynthesis, Iwatsuki et al. (1977a) measured
collagen synthesis in arteries and veins of SHR and
DOCA-salt hypertensive rats. They found that PH activity,
collagen synthesis, and collagen content were elevated in
the arterial, but not the venous, vessels of both models. It
appears that the elevations in vascular collagen synthesis
and content are limited to the portion of the vasculature
that is subjected to increased hemodynamic stress. Hume and
Bevan (1978) measured collagen synthesis in blood vessels
from rabbits with abdominal coarctation hypertension, with
sham-operated, normotensive animals serving as controls.
Collagen synthesis was increased in the arteries proximal to
the aortic constriction (thoracic aorta, ear and carotid
arteries), while collagen synthesis in arteries and veins on
the normotensive side of the ligature was not elevated.
There is also in vitro evidence supporting a regulatory
influence of arterial pressure on vascular collagen
synthesis. Leung et al. (1976) showed that collagen
synthesis of cyclically stretched arterial smooth muscle
cells (SMCs) in culture was much greater than collagen
synthesis in non-stretched control cells. They speculated
that the cyclic elevations in tension were the stimulus for
the elevated synthesis of collagen by the arterial SMCs. The
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majority of evidence, then, indicates that the elevated
vascular collagen synthesis and content observed in
experimental hypertension represents an adaptative response
to the elevated arterial wall stress caused by the
increasing blood pressure. Although accumulation of mural
fibrous protein could further exacerbate hypertension by
reducing the lumen diameter of resistance vessels (thereby
increasing peripheral vascular resistance), it is probably
not the primary cause of elevated arterial pressure in
experimental hypertension.

Chronic streptozotocin-induced diabetes (8 weeks)
significantly reduced aortic PH activity and the
incorporation of 14 c-proline into aortic collagen in the RVH
rat (Tables 2 and 3), and reduced aortic collagen synthesis
in the normotensive WKY (Table 2). The activity of prolyl
hydroxylase ia a reliable and consistent marker for the rate
of collagen biosynthesis regardless of tissue type
(Cardinale and Udenfriend, 1974), and although PH activity
was not measured in the WKY aorta, it is likely that
diabetes reduced vascular PH activity in this group as well.
This contention is supported by both Yue et al. (1987) and
McClellan et al. (1988) who showed that STZ-diabetes reduced
PH activity in granulation (neovascular) tissue recovered
from cyclinders implanted subcutaneously in normotensive
rats. In general, the results of the present study suggest
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that diabetes does reduce net collagen synthesis in both the
hypertensive and normotensive rat aorta.

Diabetes may affect collagen synthesis through an
inhibition of amino acid transport. Although this
possibility can not be entirely excluded, there is
circumstantial evidence suggesting that it does not
significantly contribute to the reduction in collagen
synthesis observed with diabetes. It was shown in this
laboratory (unpublished) that chronic STZ diabetes did not
reduce aortic proline pools in the SHR or WKY rat. Pain and
Garlick (1974) found that experimental diabetes did not
change the ratio of tissue to plasma free tyrosine specific
activity in the rat heart in vivo, indicating that diabetes
did not interfere with the transport of the amino acid into
the tissue. Furthermore, the rate of amino acid
incorporation into protein was reduced in cell-free skeletal
muscle preparations derived from diabetic rats (Wool et al.,
1968; Pain, 1973). These results seem to indicate that
diabetes reduces collagen biosynthesis by a mechanism
independent of a reduction in amino acid uptake by the
vascular smooth muscle cell.

The argument could be raised that the apparent
reduction in collagen synthesis caused by diabetes is simply
an artifact of an underhydroxylation of collagen (Schneir et
al., 1985; Yue et al., 1987), since the accumulation of
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radiolabelled hydroxyproline in collagen is used to quantify
collagen synthetic rates. However, expressing collagen
synthesis as the specific activity of hydroxyproline (dpm
hypro per umole hypro) in collagen (Table 2) tends to rule
out any artifact due to underhydroxylation.

Collagen synthesis as measured in this study is
actually "net" collagen synthesis, or total synthesis mi.nus
degradation. It is therefore possible that part of the
reduction in vascular collagen synthesis caused by diabetes
is due to increased collagen catabolism. Experimental
diabetes increases collagen degradation (i.e. reduces
content) in skin, tendon, and gingival tissue of the rat
(Schneir et al., 1982; Schneir et al., 1984a; Leung et al.,
1986). Conversely, collagen content is increased, and
collagen turnover is reduced in the diabetic rat heart,
suggesting that the degradation of myocardial collagen is
reduced by diabetes (Reddi, 1988). Schneir et al. (1979)
found that although STZ-diabetes (20 days) reduced the
specific activity of hydroxyproline in aortic collagen of
the normotensive rat, diabetes did not affect the
degradation of collagen in this tissue. In this same study,
diabetes significantly reduced the specific activity of
hydroxyproline in collagen (i.e. collagen synthesis) as well
as collagen content in rat skin. Therefore, enhanced
co-llagen catabolism is likely to contribute modestly, if at
all, to the reduction in net vascular collagen synthesis
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observed with diabetes. It is reasonable to conclude, then,
that the reductions in aortic PH activity and net collagen
synthesis observed in this study represent a true reduction
in the rate of collagen biosynthesis in the diabetic rat.

Aortic collagen concentration (runole hydroxyproline per
mg. Lowry protein) was also determined 6 and 12 weeks
following surgery (Table 4).

Although there were no

statistically significant differences among any of the
means, certain trends are suggested by the data.
Renovascular hypertension (6 and 12 weeks) tended to reduce
aortic collagen concentration. This initially may seem
paradoxical, but aortic noncollagen protein content was
shown to increase at a greater rate than aortic collagen
content in short-term (<10 weeks) hypertension (Wolinsky,
1972; Faley et al., 1985). Under these circumstances,
vascular collagen concentration could decrease despite
elevations in collagen synthesis and absolute content.
Vascular collagen content was not measured in this study, so
this relationship could not be examined. Diabetes tended to
increase collagen concentration in the RVH aorta without
affecting concentration in the WKY vessel. A
diabetes-induced increase in collagen concentration may also
seem paradoxical, but recent information can explain this
effect. The hyperglycemia of diabetes increases
non-enzymatic glycosylation of aortic collagen which
enhances the formation of glucose-derived crosslinks, or,
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ketoamine Amadori products (Brownlee et al., 1986;
Andreassen and Oxlund, 1987). These crosslinkages mature
over time by the late-stage Maillard browning reaction
forming highly stable, enzyme-resistant advanced
glycosylation collagen adducts (Monnier et al., 1988).
Diabetes reduces the synthesis (Arnquist and Dahlquist,
1979; Pain and Garlick, 1974) and increases the degradation
(Williams et al., 1980; Dice et al., 1978) of noncollagen
protein, so it is very likely that diabetes
disproportionately increases the degradation of noncollagen
protein relative to the highly crosslinked collagenous
protein, resulting in an increase in aortic collagen
concentration. These results merely illustrate that diabetes
can affect the composition of the arterial wall by
indirectly modifying collagen structure.

The finding in this study that chronic experimental
diabetes significantly reduced aortic collagen biosynthesis
in both the renovascular hypertensive (RVH) and normotensive
WKY rat without lowering systolic arterial pressure in
either group (Table 2 and Figure 1) tends to refute the
central hypothesis of this study. Earlier evidence from this
laboratory had indicated that diabetes reduced arterial
pressure of SHR and effected parallel reductions in vascular
collagen biosynthesis as well as PH and lysyl oxidase (LO)
activities. It was also shown that diabetes had no effect on
SAP, collagen synthesis, or collagen biosynthetic enzymes of
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normotensive rats (Rodgers et al., 1985; Sessa et al., in
preparation). This led to the hypothesis that diabetes
reduced these indices of vascular collagen synthesis through
a reduction of systolic arterial pressure, and not by a
direct mechanism. The results of the present study, however,
in which diabetes lowered vascular collagen synthesis
without lowering SAP in the RVH or WKY rats, suggest that
diabetes inhibits vascular collagen biosynthesis independent
of any associated changes in blood pressure.

There is some discrepancy between earlier findings in
this laboratory (Sessa et al., in preparation) and the
present study regarding the effect of diabetes on aortic PH
activity and collagen synthesis in the WKY rat. The 20%
reduction in PH activity in the WKY reported by Sessa et al.
was not statistically significant perhaps because of the
relatively small sample size (n=S) combined with a high
degree of variability within groups. The differences between
these two studies regarding aortic collagen synthesis in the
diabetic WKY may be explained in part by the optimization of
the incorporation conditions (i.e. Krebs-Henseleit
incubation medium). The collagen synthetic rates in the WKY
(as well as the RVH) aorta were several-fold higher in our
study compared to those reported previously. This may have
served to unmask diabetes-induced changes in collagen
synthesis that, in the prior study, went undetected because
of low basal synthetic rates. Regardless of previous
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findings, the results of the present study provide strong
evidence that diabetes reduces collagen biosynthesis in the
normotensive WKY rat aorta.

Although experimental diabetes has consistently been
shown to reduce collagen and noncollagen protein synthesis
in VSM, the mechanism for this effect has not been
determined. Schneir and coworkers (1979) first reported that
STZ diabetes (20 days) reduced aortic collagen synthesis in
the normotensive rat in vivo. There also appears to be a
defect in vascular collagen synthesis in a genetic model of
diabetes. Aortic explant-derived SMCs from the spontaneously
diabetic BB rat synthesize less collagen and contain lower
amounts of extracellular matrix collagen than aortic SMCs
from the non-diabetic control strain (Bowersox and Sorgente,

1985). Experimental diabetes has a duration-dependent
inhibitory effect on the incorporation of 14 c-leucine into
noncollagen protein in the rat aorta in vitro. Noncollagen
protein synthesis was unaffected after one week, moderately
reduced after 2 weeks, and severely impaired after 5 weeks
of STZ-diabetes (Arnquist and Dahlquist, 1979). It has been
observed in this laboratory (unpublished) that diabetes also
reduces the incorporation of 3 H-leucine into total protein
in the rat aorta, but to a lesser degree than the
·
'
·incorporation
of

14 c

. t o co 11 agen. Th.is suggests
-pro l'1ne in

that the effect of diabetes on vascular collagen synthesis
is more pronounced than its effect on noncollagen protein
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synthesis in the vasculature, but the mechanism for this
selectivity has not been investigated in this tissue.

The derangements in collagen and noncollagen protein
biosynthesis caused by diabetes are not confined to the
vasculature, but are observed in non-vascular tissue as
well. Williams et al.

(1980) found that alloxan-induced

diabetes reduced the incorporation of 14 c-phenylalanine into
total protein in both the isolated working rat heart as well
as isolated rat cardiac myocytes. Similarly, Reddi (1988)
reported that diabetes (4-6 weeks) reduced in vivo
myocardial collagen and total protein synthesis in the rat
The incorporation of

3

H-leucine into protein is also reduced .

in dorsal root afferent neurons of STZ-diabetic rats
(Sidenius and Jakobien, 1982). Collagen synthesis in the
skin of streptozotocin diabetic rats is reduced compared to
that of non-diabetc rat skin (Schneir et al., 1979).
However, diabetes has variable effects on the synthesis of
collagen in skin fibroblasts in

vit~o.

Collagen synthesis in

dermal fibroblasts from human diabetics was found to be
either elevated (Rowe et al., 1977: Smith and Silbert,
1981), reduced (Seibold et al., 1981), or unchanged
(Kjellstrom and Malmquist, 1984). Both collagen and
noncollagen protein synthesis in dermal fibroblasts isolated
from the diabetic rat were no different than non-diabetic
control fibroblasts (Spanheimer et al., 1987). These
variable findings in skin fibroblasts help to explain the
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poor wound healing and skin thickening (scleroderma)
sometimes observed in diabetic patients, and may merely
represent the heterogeneity of the diabetic complications
observed in these subjects. More recently, Spanheimer et al.
(1988a) showed that the effect of diabetes on collagen and
noncollagen protein synthesis in rat bone and cartilage
depends upon its severity. Moderate diabetes (STZ 35-65
mg/Kg, i.v.) reduced collagen synthesis by approximately 50%
in both tissues, whereas severe diabetes (>65 mg/Kg STZ)
produced only a 30% reduction in noncollagen protein
synthesis in both bone and cartilage. Furthermore, diabetes
decreased collagen synthesis to a greater degree than
noncollagen protein synthesis regardless of the severity of
diabetes. Umpierrez et al. (1987; 1988) found that collagen
synthesis was decreased in articular cartilage from
streptozotocin diabetic rats, and that the magnitude of this
)

effect was dependent on the severity of diabetes. Although
noncollagen protein synthesis was reduced in the cartilage
from severely diabetic animals, this effect was less marked
than the effect on collagen synthesis. Overall, diabetes
appears to have a more specific inhibitory effect on
collagen versus noncollagen protein synthesis in both
vascular and nonvascular tissue, suggesting that the
widespread

reductions in protein synthesis caused by

diabetes are more selective for collagen and therefore may
share a common etiology.
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There are a number of possible mechanisms for the
inhibition of vascular collagen synthesis by diabetes which
are independent of hemodynamic changes. The hormonal
imbalances and metabolic aberrations of diabetes, especially
the lack of insulin, would appear to be the most logical
explanation for the changes observed in the diabetic
vasculature. The effect of insulin on collagen synthesis in
vascular SMCs in vitro has remained largely unexplored,
while the effect of insulin on noncollagen protein synthesis
in these cells has been more thoroughly investigated.
Mikkonen et al. (1966) reported that insulin markedly
increased the incorporation of 14 c-proline into collagen in
granulation (neovascular) tissue of the rat in vitro.
However, Jarvelainen et al. (1987) showed that physiological
concentrations of insulin (0.01 and 0.10 mU/mL) had no
effect on collagen synthesis in human aortic smooth muscle
cells in vitro. Insulin (0.025-25 mU/mL) was shown to
enhance the synthesis of proteoglycans (a component of the
SMC extracellular matrix) in porcine aortic smooth muscle
cells cultured in serum-free media, although the maximum
stimulation achieved with insulin was only 60-80% of that
obtained with 10% fetal calf serum (Breton et al., 1988).
Supraphysiological concentrations of insulin (10-100 mU/mL)

in vitro increase noncollagen protein synthesis in the
bovine mesenteric artery (Arnquist, 1974) but not in the rat
aorta (Arnquist and Dahlquist 1979). In general, treatment
of diabetic animals with insulin in vivo has a much more
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dramatic effect on vascular protein synthesis than
incubation of vascular tissue with insulin in vitro. Two
week insulin treatment in vivo restored aortic noncollagen
protein synthesis to levels observed in the non-diabetic
control rat (Arnquist and Dahlquist, 1979). Later, it was
shown that once daily insulin treatment for 48 hours was
necessary for the restoration of aortic protein

s~nthesis

in

the diabetic rat, and that treatment for 12 or 24 hours did
not increase noncollagen protein synthesis in the aorta
(Arnquist and Norby, 1980). In this study insulin did not
have a stimulatory effect on protein synthesis in vitro
unless 5% fetal bovine serum was present in the incubation
medium. These results led Arnquist and Norby (1980) to
conclude that the increase in aortic protein synthesis
observed with insulin treatment in the diabetic rat was the
result of the normalization of the diabetic state rather
than a direct action of the hormone itself. However, the
inability of insulin to stimulate protein synthesis in vitro
does not rule out a trophic effect of insulin on vascular
smooth muscle. Miller et al. (1984) have shown that
triiodothyronine (T ) and cortisol are both required for
3
insulin to completely restore the activity and the proper
regulation of glycogen synthase in diabetic rat hepatocytes
in vitro. Thus, the equivocal results obtained with insulin
and VSM collagen and noncollagen protein synthesis in vitro
may reflect the absence of proper cofactors needed for an
insulin-induced activation of protein synthesis.
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Insulin also has a stimulatory effect on cell growth
(quantified by mean cell count and/or

3

H-thymidine

incorporation into DNA) in vascular smooth muscle cells
derived from a variety of species. It is possible that
insulin may have a similar effect on VSM collagen synthesis
as well. The addition of insulin (0.01-10 mU/mL) to cultured
human (Pfeifle et al., 1981), non-human primate (Stout et
al., 1975), and bovine (King et al., 1985) aortic SMCs under
non-growing conditions was found to dose-dependently
stimulate cell proliferation. A dose-dependent increase in
DNA synthesis was obtained with insulin (0.01-10 mU/mL) in
rat (Pfeifle et al., 1980; Taggart and Stout, 1980) and
bovine (King et al., 1983), but not rabbit (Ledet,
1976;1977), aortic SMCs in culture. A common feature of
these studies is that insulin was approximately 3-5 times
less effective in stimulating SMC growth than a high
concentration of serum (5-10%) containing comparitively low
levels of insulin (0.003-0.005 mU/mL). However, Stout et al.
(1975) observed that removal of insulin from the serum prior
to addition significantly attenuated the mitogenic effect of
the high concentration. These results indicate that while
insulin has a proliferative effect on cultured arterial
smooth muscle cells, other serum factors are also involved
in the overall regulation of SMC replication. Regardless,
'

the stimulatory effect of . insulin on SMC proliferation may
have an attendant effect on the rate of collagen synthesis
in this cell type. However, this is not likely as there
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seems to be an inverse relationship between the mitotic
activity of the arterial SMC and the synthesis of collagen.
The rate of collagen synthesis in bovine aortic SMCs is very
low during the time period after initial seeding (when the
cells are rapidly dividing), while the rate of collagen
synthesis markedly increases as the cells approach and reach
confluence (Stepp et al., 1986).

Another approach to examining the effect of diabetes on
vascular collagen synthesis is incubating tissue or cultured
cells with serum from diabetic animals and assessing the
effect on protein synthesis. The effect of diabetic rat
serum (DRS) on collagen and noncollagen protein synthesis
has been well-characterized in non-vascular tissue such as
dermal fibroblasts and costal cartilage of the rat.
Spanheimer et al. (1988b) demonstrated that diabetic serum
dose-dependently reduced collagen synthesis in non-diabetic
costal cartilage compared to buffer-incubated control
tissue. Diabetic serum also reduced noncollagen protein
synthesis in costal cartilage, but the concentration
required for maximal inhibition was 2-fold greater than that
required for maximal inhibition of collagen synthesis. This
indicates that collagen synthesis in cartilage is more
sensitive to the inhibitory effect of DRS than noncollagen
protein synthesis. Using molecular sieve chromatography, it
was determined that the inhibitory activity of DRS was
present in the high molecular weight (> 5000 daltons)

44
fraction. Spanheimer et al. (1987) obtained similar results
using diabetic rat serum and rat dermal fibroblasts. They
found that DRS reduced collagen synthesis to a greater
degree than noncollagen protein synthesis at every
concentration studied, and that again the high molecular
weight fraction (> 5000 daltons) of the serum was
responsible for the observed changes in fibroblast collagen
and noncollagen protein synthesis. These findings are
supported in part by those of Phillips et. al (1979) who
showed that serum from diabetic rats contained a factor that
inhibited both
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3

H-uridine incorporation into RNA and

.
.
.
s-su lf ate incorporation
into
mucopo 1 ysacc h ari. d e

(proteoglycan) in rat costal cartilage. Furthermore, the
ability of normal rat serum (NRS) to stimulate RNA and
mucopolysaccharide synthesis was reduced or abolished by the
addition of DRS, indicating that DRS contained an inhibitory
factor instead of lacking a stimulatory one. Phillips termed
this factor the "somatomedin-inhibitor" because RNA and
mucopolysaccharide synthesis in rat costal cartilage is
considered to be an index of somatomedin bioactivity. It is
possible that the respective collagen and proteoglycan
synthesis inhibitors described by Spanheimer et al. and
Phillips et al. are one in the same, as the putative
"somatomedin-inhibitor" of Phillips was also present in the
high molecular weight fraction of DRS. However, there is no
direct evidence either supporting or refuting this
possibility. More recently, Spanheimer et al. (1988c) have
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better-characterized the inhibitory factor(s) present in DRS
using rat dermal fibroblasts. They discovered that the
inhibitory component of DRS was in the 20-40,000 dalton
molecular weight range, and that . it could be inactivated by
either heat (60°c x 1 hr.) or trypsin treatment, indicating
a proteinacious substance. To further study the mechanism by
which DRS reduced collagen synthesis, Spanheimer et al.
(1988c) isolated RNA from fibroblasts incubated for 24 hours
in either NRS or DRS and measured its translation in a
cell-free reticulocyte lysate system. The translation of
procollagen mRNA obtained from fibroblasts incubated in DRS
was significantly lower than the translation of procollagen
mRNA isolated from cells incubated in NRS. Furthermore, the
ratio of procollagen to noncollagen protein mRNA translation
was 84% lower in RNA isolated from DRS- versus NRS-incubated
fibroblasts, indicating a specific reduction in the
translation of procollagen mRNA upon exposure to DRS. This
suggests that the inhibitory component of DRS affects
collagen synthesis in rat dermal fibroblasts at a
pre-translational step, as evidenced by the selective
reduction in the translation of procollagen mRNA in a
standard RNA translation assay system.

Perhaps similar studies using vascular smooth muscle
cells will reveal a mechanistically analagous effect of
diabetes or diabetic serum on collagen synthesis in this
cell type. However, there is only one report in the
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literature, to my knowledge, that has examined the effect of
diabetic serum on VSM protein synthesis in vitro.
Jarvelainen et al. (1987) reported that serum from human
diabetics in "poor" metabolic control increased collagen
synthesis in human aortic smooth muscle cells compared to
serum from non-diabetic controls, whereas serum derived from
diabetics with "good" metabolic control had no effect on
collagen synthesis in these cells. The significance of this
finding is unclear at this time, especially in light of the
fact that diabetes reduces collagen and noncollagen
biosynthesis in virtually every tissue studied thus far.
More studies are needed, then, to better-characterize the
effect of diabetic serum on VSM collagen biosynthesis and to
assess its relevance to the effect of diabetes on collagen
synthesis in this tissue in vivo.

The abnormal metabolic environment, such as the
hyperglycemia and hyperketonemia of diabetes, could
contribute to the altered vascular connective tissue
synthesis observed in animal models of this disease. There
are very few reports in which the direct effect (i.e.
without the presence of serum) of ketones or excess glucose
on protein synthesis have been studied in vitro. Arnquist
and Dahlquist (1979) found no effects of glucose (400 mg/dL)
14 c 1
·
t ion
·
·
·
·
on th e incorpora
of
- eucine
into
nonco 11 agen protein
in the rat aorta in vitro. Glucose (150 mg/dL) slightly
blunted the production of type I collagen in rabbit aortic
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medial cell cultures, while it had no effect on type III
collagen or fibronectin production in these cells (Ledet and
Vuust,1980). Ketones (0.20 mM acetoacetate) had no effect on
the synthesis of either collagen type or fibronectin in this
study. Glucose (700 mg/dL) attenuates the stimulatory effect
of insulin on collagen and noncollagen protein synthesis in
human skin fibroblasts in vitro (Kjellstrom and Malmquist,
1984). Spanheimer et al. (1988b) observed that normal rat
serum (NRS) stimulated collagen and noncollagen protein
production in rat costal cartilage in vitro, and they
examined the ability of glucose and ketones to affect this
phenomenon. Glucose in a concentration of 300 mg/dL or less
did not affect NRS-stimulated collagen or noncollagen
protein synthesis in rat cartilage, while concentrations of
600 and 900 mg/dL . attenuated the stimulatory effect of NRS
on collagen, but not noncollagen, protein synthesis.
Conversely, ketones (20 mM beta-hydroxybutyrate) slightly
reduced the effect of NRS on noncollagen protein synthesis
without affecting NRS-stimulated collagen synthesis. This
study did not, however, clearly examine the direct effects
of glucose and ketones on collagen and noncollagen protein
synthesis, but it did demonstrate that these molecules can
affect protein synthesis under certain conditions. Excess
glucose and ketones seem to reduce the responsiveness of
certain tissues to stimulatory influences (such as normal
serum or insulin) in vitro without directly affecting tissue
function itself. These studies suggest, then, that the
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abnormal metabolic environment may contribute to the
impaired arterial collagen synthesis characteristic of
diabetes, but that it does not appear to play a direct role
in this phenomenon.

Hypothyroidism attends both clinical (Pittman et al.,
19794 and experimental (Rodgers, 1986; Table 1) diabetes,
and may therefore be involved in the reduction of vascular
collagen biosynthesis observed in diabetic animals.
Unfortunately, there is a paucity of studies examining the
direct effect of thyroid hormones (T

and T ) on vascular

4

3

smooth muscle collagen synthesis in vitro. Mikkonen et al.
(1966) found that T
.
.
incorporation
of

14

4 treatment in vivo slightly reduced the
.
C-pro l"ine into
co 11 agen an d nonco 11 agen

protein in rat granulation tissue in vitro, while T

3

(10- 4 -10- 3M) added to tissue in vitro slightly increased
both collagen and noncollagen protein synthesis. Brosnan et
al. (1973) reported that thyroxine (T ) treatment (3 weeks)

4

reduced aortic collagen content in the hypophysectomized dog
(hypophysectomy itself did not affect aortic collagen
content). Thyroid hormones have an entirely different effect
on protein synthesis in the heart. Thyroxine treatment in
vivo increases total cardiac protein synthesis measured in
vitro in the rabbit (Parmacek et al., 1986), dog (Bonnin et
al., 1983), and rat (Siehl et al., 1985), while T

3

directly

stimulates total protein synthesis in fetal mouse heart
cells in culture (Crie et al., 1983). Thyroxine treatment in
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vivo also causes the development of cardiac hypertrophy in
the rat and rabbit (Tanaka et al., 1985; Parmacek et al.,
1986). The stimulatory effect of T

3

and T

4

on cardiac

protein synthesis, however, may be unique to that tissue,
because thyroid hormones were found to reduce proteoglycan,
collagen, and noncollagen protein synthesis in skin
fibrobalsts (de Rycker et al., 1984; Shibasha et al., 1988)
and osteoblasts (Ernst and Froesch, 1987) in culture. The
thyroid hormones are well established anabolic regulators of
the myocardium, while their role in the regulation of
vascular tissue still remains obscure. Recently, it was
shown that T

3

replacement therapy reverses the impaired

cardiac performance of STZ-diabetic rats nearly as
effectively as does insulin repiacement (Davidoff and
Rodgers, submitted). There is insufficient evidence in the
literature, however, to support a causal relationship
between the hypothyroidism and the decrease in vascular
· collagen synthesis of diabetes. The little indirect evidence
that does exist, in fact, suggests that T

3

and T

may

4

reduce, rather than stimulate, collagen synthesis in the
vasculature. The studies of Miller et al. (1984; 1986) using
diabetic rat hepatocytes have demonstrated that T

3

and T

4

have an obligatory role in modulating tissue response to
other circulating hormones such as insulin, and it is
possible that this may be true in vascular tissue as well.
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Finally, it is possible that the autonomic neuropathy
characteristic of diabetes may be involved in the
diabetes-induced reduction in vascular collagen synthesis. A
possible link between diabetic autonomic neuropathy and
vascular collagen synthesis comes from indirect evidence
supporting a stimulatory effect of catecholamine and
adrenergic innervation on vascular smooth muscle cell
protein synthesis. Diabetic autonomic neuropathy is
characterized by morphological alterations of both
sympathetic and parasympathetic nerve fibers including
neuroaxonal dystrophy (accumulation of abnormal subcellular
structures), axonal swelling, and general axonopathy
(Tomlinson and Mayer, 1984; Yagihashi and Sima, 1986;
Schmidt and Plurad, 1986). Diabetic nerves are also more
susceptible to ischemic damage and have an impaired ability
to regenerate upon injury (Nukada, 1986; Longo et al.,
1986). Nerve conduction velocity as well as axonal transport
of neurotransmitters and their biosynthetic enzymes are
reduced or impaired in diabetes (Troni et al., 1984;
Tomlinson and Mayer, 1984). These latter defects have been
linked to endoneurial sorbitol accumulation and myoinositol
depletion in diabetic nerve (Greene et al., 1988). Tomlinson
and Yusof (1983) indirectly demonstrated a reduced
norepinephrine release from adrenergic neurons with
electrical stimulation in the alloxan-diabetic rat. Some
studies provide indirect evidence suggesting that
catecholamines have a regulatory influence on VSM collagen
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synthesis and vascular geometry. Chronic adrenergic
denervation significantly reduced both medial thickness and
cross-sectional area in the central ear artery of the rabbit
(Bevan and Tsuru, 1981; Bevan, 1984). The sympatholytic
antihypertensive agents (e.g. reserpine, clonidine) reduce
vascular collagen and noncollagen protein synthesis and
content to a greater degree than do non-sympatholytic agents
causing equivalent reductions in blood pressure (Ooshima et
al., 1974; Spector et al., 1978; earlier and Rorive, 1985).

In addition, non-sympatholyic antihypertensive drugs
(hydralazine, captopril) were found to prevent or reverse
elevations in systolic arterial pressure in the SHR and
Goldblatt RVH rat without affecting the .vascular hypertrophy
characteristic of clinical and experimental hypertension
(Rorive et al., 1980; Smeda et al., 1988). Chichester and
Rodgers (1987) showed that chronic low dose doxazosin (an
alpha adrenoceptor blocking agent) treatment reduced aortic
collagen synthesis without affecting arterial pressure in
the SHR. There is circumstantial evidence supporting an
involvement of the alpha adrenoceptor in the regulation of
collagen synthesis in vascular smooth muscle. Alpha
adrenoceptor activation in vascular smooth muscle cells
causes the release of 1,2 diacylglycerol (DAG) from membrane
phospholipids which then activates protein kinase

c

(Michell, 1983). Alpha adrenoceptor blocking agents can
antagonize this effect (Nishizuka, 1984). Phorbol esters,
which are direct activators of protein kinase

c,

increase
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collagen biosynthesis in chondrocytes (Finer et al., 1985)
and skin fibroblasts (Marian and Mazzucco, 1985). If, in
fact, alpha adrenoceptor activation increases collagen
biosynthesis in vascular smooth muscle, then a reduction of
catecholamine-mediated alpha adrenoceptor activation caused
by sympathetic autonomic neuropathy could be responsible, in
part, for the reduction in vascular collagen biosynthesis
observed with diabetes : Studies examining the effect of
alpha adrenoceptor agonists on VSM cell collagen synthesis

in vitro would provide useful information regarding the role
of catecholamines in the regulation of collagen synthesis in
VSM. Consequently, the effect of norepinephrine (NE; 10- 6 M)
on rat aortic collagen synthesis in vitro was examined in
this laboratory. Briefly, NE actually reduced collagen
synthesis in the WKY rat aorta, possibly due to a direct
toxic effect on the VSM cell. The results are presented and
discussed· in Appendix 4.
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Sunmary and Conclusions

It was shown in this study that renovascular
hypertension increased aortic collagen synthesis and PH
activity in the rat. This is in agreement with the current
literature which suggests that the elevations in vascular
collagen synthesis in experimental hypertension are
primarily the result of the distensional stress imposed on
the arterial wall by the rising blood pressure. Chronic
STZ-induced diabetes did not reduce SAP in the RVH or WKY
rat, suggesting that the pressure-lowering effect of
diabetes observed in the SHR is unique to that genetic
strain. Finally, diabetes reduced vascular collagen
synthesis in both the RVH and normotensive WKY rats, without
affecting SAP at any time during the eight-week period of
diabetes. This indicates that diabetes has an inhibitory
effect on VSM collagen biosynthesis regardless of the model
of hypertension or the strain of rat, and that these changes
in vascular collagen synthesis are independent of any
associated changes in arterial pressure. The mechanism for
the inhibition of collagen synthesis by diabetes is still
unclear, but the endocrine imbalances of diabetes, such as
hypoinsulinemia and hypothyroidism, are likely to be
responsible for this effect. However, in vivo and in vitro
insulin and thyroid hormone replacement studies will be
needed to clarify the role of these hormones in the
reduction of VSM collagen biosynthesis caused by diabetes.
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Appendix I: Effect of unlabelled proline on aortic collagen
synthesis.

A positive correlation between the extracellular total
proline concentration and the uptake of 14 c-proline has been
demonstrated in mouse Ki-3T3 cells in culture (Peterkofsky
et al., 1982). If this is true of vascular smooth muscle,

then this has interesting implications for the study of
collagen synthesis using the incorporation of 14 c-proline
into collagen in vitro. Consequently, the effect of cold
proline addition to the pulsing medium was tested in the
present assay system for the determination of collagen
synthetic rates in the rat aorta. The experiment was
performed using two 14 week-old WKY rats. Each animal was
killed by cervical dislocation, and the aorta was excised,
cut in half lengthwise, and minced. One half of each aorta
was pulsed with

14

c-proline in the presence of unlabelled

proline, while the remaining half of the aorta served as
control and did not receive cold proline addition to the
medium. The total concentration of proline in the medium was
0.0375 mM without cold proline addition and 0.2375 mM with
cold proline addition, . while the amount of radioactivity was
held constant at 10 uCi/mL.

The results of the experiment are presented in table 5.
Supplelmentation of the Krebs-Henseleit pulsing buffer with
cold proline resulted in a 6.1-fold reduction in the
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incorporation of radiolabeled proline into aortic collagen.
This treatment also caused a 5.9-fold reduction in the
·
t ion
·
· t o t o t a 1 protein,
·
incorpora
o f 14 c -pro l'ine in
expresse d
as dpm proline/umole proline (1167
addition versus 197

±

±

78 without cold proline

10 with proline addition, xl0- 3 ).

Similar changes in the synthetic rates of vascular collagen
and total proline-containing protein (a 6.4- and 7.0-fold
decrease, respectively) were also obtained when the data was
expressed as dpm imino acid per mg. protein (data not
shown). There was, however, approximately a 6.3-fold
difference in the specific activity of proline in the medium
between the two treatments.

The apparent reduction in collagen synthetic activity
observed with cold proline treatment thus appears to be the
result of the effective dilution of the radiolabel by the
unlabeled proline in the medium. Since the acid-soluble
radioactivity was not measured, it could not be directly
determined whether or not the dilution of the radiolabel in
the surrounding medium also resulted in a decrease in the
specific activity of the intracellular aortic proline pool.
However, it has been shown that changes in the specific
activity of proline in the pulsing medium are reflected in
the intracellular pool of this imino acid. Experiments using
chick embryo skeletal muscle cells {Paterson and Stiohman,
1972) indicate that 3 H-leucine in the extracellular medium
equilibrates with the intracellular free pool of this amino
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Table 5. Effect of unlabelled proline (pro) addition to the
pulsing medium on in vitro incorporation of 14-C-proline
into 14-C-hydroxyproline in the rat aorta. Values are means

+ S.D.

Collagen synthesis
(xl0- 3 )

Treatment

Proline specific activity

DPM hypro/

in the media (uCi/umole)

umole hypro

- cold pro

268.1

+ cold pro

42.1

510 + 73

The experiment was performed using 14 week-old WKY rats, n=2
for each treatment. The amount of radioactivity in the
pulsing media was identical in both treatments (lOuCi/mL)
and the concentration of proline was 0.0375mM without
unlabelled proline supplementation and 0.2375mM with
unlabelled proline supplementation.

1 signif icantly different from the minus cold pro incubation
(unpaired Student's t test, p < 0.0001).
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acid within a relatively short time span (approximately 15
minutes). Additional studies have demonstrated that there is
a rapid equilibration between amino acids in the
extracellular medium and their intracellular pool (Loftfield
et al., 1956; Fern and Garlick, 1974). It is likely that the
specific activity of the intracellular praline pool was
reduced by the addition of cold praline to the incubation
medium in this experiment. Therefore, the similar
differences in both the collagen synthetic rate and the
extracelleulr praline specific activity between the two
treatments (approximately 6-fold) suggests that there was no
real decrease in collagen synthesis per se. It suggests,
rather, that there was merely a decrease in the amount of
radioactive praline incorporated into collagen due to a
decrease in the specific activity of the intracellular
precursor pool.

Peterkofsky et al. (1982) showed that the rate of
uptake of radiolabelled praline into mouse Ki-3T3 cells was
dependent on the total extracellular praline concentration.
There was no decrease in the amount of radioactivity taken
up into Ki-3T3 cells when the radioactive praline in the
medium was diluted up to 200-fold with cold praline,
supposedly due to the stimulation of the imino acid uptake
system by the increasing extracellular praline levels.
Because the Km for praline transport (6.5 mM; Ornder et al.,
1977) is relatively high, Peterkofsky et al. (1982)
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suggested that collagen synthesis would proceed at a
suboptimal rate at the concentration of proline provided by
the addition of isotope alone. In the present experiment,
however, a 6-fold increase in the concentration of proline
in the pulsing medium (with a concomitant 6-fold decrease in
its specific activity) resulted in a nearly identical
decrease in the amount of radioactive proline incorporated
into collagen and other proteins. It is apparent, . then, that
in the present system no advantage is gained by
supplementing the pulsing medium with unlabeled proline
regardless of any effects it may have on the transport of
the imino acid into the tissue.
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Appendix II: Influence of noncollagenous protein on the
index of collagen synthesis.

A frequently reported expression of the rate vascular
collagen synthesis is DPM hydroxyproline per milligram total
protein per incubation period (Ooshima et al., 1977;
Iwatsuki et al., 1977a; Foidart et al., 1978). This
expression of collagen synthesis has potential limitations,
however, because diabetes also reduces the synthesis and
content of noncollagen protein in different tissues (Pain
and Garlick, 1974; Dice et al., 1978; Arnquist and
Dahlquist, 1979). This could lead to an underestimation of
the effect of diabetes on aortic collagen synthesis. A
reduction in the denominator (total Lowry protein) would
artificially inf late the calculated value for collagen
synthesis in the diabetic animals, which could partially or
entirely mask a true effect of diabetes. Despite this
concern, diabetes was found to reduce aortic collagen
biosynthesis in both the RVH and WKY rat (Table 6). However,
in the RVH group this effect was not as pronounced as when
the data was expressed as DPM hypro per umole hypro (Table
2). Overall, expressing collagen synthesis as DPM hypro per
mg. protein did not change the qualitative effect of
diabetes on this measurement in the hypertensive or
normotensive rat aorta.

Using the alternative index of collagen synthesis did,
however, mask elevations in aortic collagen biosynthesis
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Table 6. Aortic collagen synthesis in renovascular
hypertensive (RVH) and Wistar-Kyoto (WKY) rats 6 and 12
weeks following surgery. The 12 week animals were sacrificed
8 weeks after STZ injection. Values are means + S.D.

Collagen Synthesis (xl0- 3 )

(DPM hypro/ mg. protein)
Group

Treatment

n

6 weeks

RVH

control

8

14.9 + 7.6

diabetic

8

control

7

WKY

diabetic

11.4 + 9.6

.

n

12 weeks

7

31.3 + 14.1

7

19.3 +

5

33.7 + 12.7

7

9.2 +

9.2 2

2.4

2 signif icantly different from control of the same group.

2
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(Table 6) that were observed when synthesis was expressed as
the specific activity of hydroxyproline in collagen. This
apparent lack of a hypertension-induced enhancement of
vascular collagen synthesis may be explained by the findings
of Wolinsky (1971; 1972). He showed that there was a
disproportionate increase in the accumulation of
noncollagenous versus collagenous protein in the RVH rat
aorta after 10 weeks of hypertension. However, the
accumulation of collagenous protein continued to increase
beyond this time point, whereas there was no further
accumulation of noncollagenous protein with long-term
hypertension (64 weeks). The absence of elevated vascular
collagen synthesis in the RVH rats (Table 6) probably
reflects concurrent increases in both collagen and
noncollagen protein deposition. If the duration of
hypertension was extended beyond the 12 week period used in
this study, then perhaps an increase in the synthesis of
collagen per mg. protein would be observed in the RVH aorta.
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Appendix III: Serum glucose, insulin, thyroid hormones and
aortic collagen synthesis of WKY and RVH rats
3 weeks after STZ injection.

Collagen synthesis was measured in RVH diabetic, RVH
non-diabetic, and WKY non-diabetic rats 3 weeks following
STZ injection (Table 7) in order to gain a better
understanding of the temporal relationship between the onset
of diabetes and the reduction in vascular collagen
synthesis. Surprisingly, the severity of diabetes in these
animals was in question, and therefore the collagen
synthesis values for this study were not presented in the
main body of the thesis. However, there is some conflict
among the several indexes used to verify the presence of
diabetes (Table 8). The two most direct measures of
diabetes, serum glucose and serum insulin levels, indicate
that the STZ-injected animals were not diabetic. The serum
insulin levels of the non-diabetic RVH and WKY rats were
well below normal values, rendering the validity of these
measurements suspect. It is interesting to note that the
diabetic RVH rats lost body weight and were hypothyroid
compared to the non-diabetic groups. These indexes were
within the expected ranges for diabetic rats, suggesting
that at least some degree of diabetes was present. Although
the measurements used to verify the presence of diabetes
were not in complete agreement, it appears that the RVH rats
injected with STZ were at least somewhat diabetic, as there
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is no other apparent explanation for the co-occurance of
weight loss and hypothyroidism in these animals.

Table 7. The effects of STZ diabetes of 3 weeks duration (6
weeks after renal artery clipping) on aortic collagen
concentration and synthesis in the RVH and WKY rat. Values
are means + S.D. and collagen synthesis and concentration
are expressed as dpm hypro per umole hypro (xlO -3 ) and nmole
hypro per mg. protein, respectively.

Collagen

Collagen

Group

n

Concentration

Synthesis

RVH-C

8

385 + 68

40.1 + 23.5

RVH-D

8

431 + 56

24.6 + 8.4 2

WKY-C

7

444 + 86

24.1 + 18.0

2 signif icanly different from the control of the same group
(p < 0.05, unpaired Student's t test)
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Table 8.

Final body weight and serum values 3 weeks after

STZ injection (6 weeks following surgery) in RVH and WKY
rats. Value are means + S.D.

Glucose

Insulin

Group *

(mg/dL)

(uU/mL)

(ug/mL)

(ug/mL)

RVH-control

91

12.8

83.0

5.21

RVH-diabetic

WKY-control

*The

+ 12

+ 6.0

137

8.8

+ 32

+ 2.5

121

24.4

+ 34

+ 11. 6

±

+ 0.69

+ 5.2

55.7 1

3.70 1

+ 17.1

82.1

+ 1. 47

5.03

+ 4.0

body weights (BW) for the groups are 322

34, and 322

T4

T3

±

+ 0.64

19, 266 +

16 for the RVH-control, RVH-diabetic, and

WKY-control, respectively. The BW of the RVH diabetic group
is significantly different from its control (unpaired
Student's t test, p < 0.05)

1 significantly different from the control of the same group.
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The collagen synthetic rates in the RVH and WKY
non-diabetic control groups of this study were lower than
those measured in the animals sacrificed 12 weeks following
surgery. This may not be a valid comparison, however,
because aortic collagen synthesis in these two studies was
measured in separate assays performed on different days.
Therefore the difference in synthetic rates between these
two_ studies may represent inter-assay variability. This is
difficult to explain at the present time because the same
methodology was used in both of the studies. Aortic collagen
synthesis in RVH rats 3 weeks after STZ injection was
significantly lower than that in the corresponding
vehicle-injected controls. If the assumption that the
STZ-injected RVH rats were at least mildly diabetic is
valid, then it appears that vascular collagen synthesis is
reduced 3 weeks after the onset of diabetes. This is in line
with the findings of Arnquist and Dahlquist (1979), who
showed that diabetes reduced aortic noncollagen protein
synthesis in the rat as early as 2 weeks after the induction
of experimental diabetes. There were no significant
differences in aortic collagen concentration among any of
the groups, and no trends were apparent. Perhaps it was too
early in the · course of either hypertension or diabetes for
any changes in the composition of the arterial wall to be
observed. The results of Arnquist and Dahlquist and of this
study suggest that the reductions in vascular protein
synthesis occur relatively early in the course of diabetes.
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Appendix IV: Reduction of aortic collagen synthesis by
norepinephrine in vitro.
The possible stimulatory influence of alpha
adrenoceptor activation on VSM collagen synthesis led us to
test the effect of the catecholamine norepinephrine (NE) on
aortic collagen biosynthesis in the rat. Fourteen week-old
WKY rats were killed by cervical dislocation, and the aortas
were excised, cut in half longitudinally, and minced.
Collagen synthesis was measured using the protocol outlined
in Methods. Norepinephrine significantly reduced the
incorporation of 14 c-proline into collagen in the WKY rat
aorta (Table 9). Roughly equivalent reductions in collagen
synthesis were observed when the data was expressed as
either DPM hypro per mg. protein or DPM hypro per umole
hypro. Although these results do not directly support the
above hypothesis, definitive conclusions can not be drawn
from these data. The VSM cell is rarely exposed to the
concentration of NE used in this study (l0- 6 M), so it is
possible that the hormone had a toxic effect on the tissue.
A complete dose-effect relationship must be determined
before the involvement of catecholamines in the regulation
of VSM collagen synthesis can be critically evaluated.
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Table 9. The effect of norepinephrine (NE; 10- 6M) on aortic
collagen synthesis in the WKY rat. Values are means ± S.D.
Collagen Synthesis (x l0- 3 )a
dpm/ mg. protein

dpm/ urnole hypro

5

422.3 + 109.0

781.1 + 108.7

5

116.9 + 33.8 1

284. 5 + 71. 9 1

Treatment

n

Control

NE

aData is expressed as DPM hydroxyproline per mg. protein and
dpm hydroxyproline per micromole hydroxyproline (specific
activity) 1 significantly different from control (p < .001)
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